Mirit Avram, M.D. Internal Medicine - Geriatric Medicine Medicare: Medicare Enrolled Practice Location: 2210 E Calvada Blvd, Pahrump, NV 89048 Phone: 775-727-6400 Fax: 775-727-7543 |
News Archive
Hard to Treat Diseases (HTDS; http://www.htdsmedical.com/) and its operating subsidiary Slavica BioChem want to point the shareholders back to the press release from Oct 29, 2009, where the company announced news about a possible merger with a EU based, stem-cell research company.
Researchers at The Feinstein Institute for Medical Research have discovered that tanshinones, which come from the plant Danshen and are highly valued in Chinese traditional medicine, protect against the life-threatening condition sepsis. The findings are published in the December issue of Biochemical Pharmacology.
The Institute for Systems Biology (ISB) of Seattle, WA, is collaborating with the Gladstone Institute of Neurological Disease (GIND) and its Taube-Koret Center for Huntington's Disease Research to use whole-genome sequencing to identify genes and novel drug targets related to the onset and progression of Huntington's disease (HD). The research team, led by GIND associate director and senior investigator Steven Finkbeiner, MD, PhD, will also use induced pluripotent stem (iPS) cells from patients with HD to screen for drugs that might delay, prevent, or even reverse this devastating condition.
Although President Barack Obama continues to make clear that, in his view, reforming these entitlement programs is necessary to find budget savings, one policy expert says such cuts might have very little impact on deficit spending. Meanwhile, news outlets report on how lobbyists are taking position in an effort to best advance their clients interests to the deficit panel.
› Verified 6 days ago